Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 13, 1999

View Archived Issues

New European Commission Structure Leaves Questions

U.S. FDA Gives First-Ever Approval To Proneuron For Spinal Cord Cell Therapy Test

UK Researchers Show Drug Reduces Tumor Blood Flow

Trials Begin For Bayer's 1st German Biotech Product

Chemunex Launches New Test For E. Coli In Drinking Water

Focus On New Peptide Could Herald Lifetime Flu Vaccine

NicOx Launches $34M IPO To Speed Up Its R&D Efforts

MediGene In-Licenses Its Phase II-Ready CHF Drug

Alchemia To Build Pilot Plant For Carbohydrate Production

Genetically Modified Tomato Gets 'Amber Light' From EU

Other News To Note

European Biotech Community Denounces

Inpharmatica Unveils Database On Structure-Function Relationships

VitaResc Extends Product Pipeline With SIRS Drug

Genset Finds Schizophrenia Gene Through Janssen Collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...